Literature DB >> 19713770

DNA damage-induced cell death is enhanced by progression through mitosis.

Hanne Varmark1, Cynthia A Sparks, Joshua J Nordberg, Birgit S Koppetsch, William E Theurkauf.   

Abstract

Progression through the G(2)/M transition following DNA damage is linked to cytokinesis failure and mitotic death. In four different transformed cell lines and two human embryonic stem cell lines, we find that DNA damage triggers mitotic chromatin decondensation and global phosphorylation of histone H2AX, which has been associated with apoptosis. However, extended time-lapse studies in HCT116 colorectal cancer cells indicate that death does not take place during mitosis, but 72% of cells die within 3 days of mitotic exit. By contrast, only 11% of cells in the same cultures that remained in interphase died, suggesting that progression through mitosis enhances cell death following DNA damage. These time-lapse studies also confirmed that DNA damage leads to high rates of cytokinesis failure, but showed that cells that completed cytokinesis following damage died at higher rates than cells that failed to complete division. Therefore, post-mitotic cell death is not a response to cytokinesis failure or polyploidy. We also show that post-mitotic cell death is largely independent of p53 and is only partially suppressed by the apical caspase inhibitor Z-VAD-FMK. These findings suggest that progression through mitosis following DNA damage initiates a p53- and caspase-independent cell death response that prevents propagation of genetic lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713770      PMCID: PMC2897049          DOI: 10.4161/cc.8.18.9539

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  41 in total

Review 1.  Caspase structure, proteolytic substrates, and function during apoptotic cell death.

Authors:  D W Nicholson
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

2.  mus304 encodes a novel DNA damage checkpoint protein required during Drosophila development.

Authors:  M H Brodsky; J J Sekelsky; G Tsang; R S Hawley; G M Rubin
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

Review 3.  Cellular senescence: when bad things happen to good cells.

Authors:  Judith Campisi; Fabrizio d'Adda di Fagagna
Journal:  Nat Rev Mol Cell Biol       Date:  2007-09       Impact factor: 94.444

4.  Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis.

Authors:  Lindsey A Allan; Paul R Clarke
Journal:  Mol Cell       Date:  2007-04-27       Impact factor: 17.970

Review 5.  Death through a tragedy: mitotic catastrophe.

Authors:  H Vakifahmetoglu; M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2008-04-11       Impact factor: 15.828

6.  The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01.

Authors:  P R Graves; L Yu; J K Schwarz; J Gales; E A Sausville; P M O'Connor; H Piwnica-Worms
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

7.  Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation.

Authors:  Celia Vogel; Christian Hager; Holger Bastians
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

8.  Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139.

Authors:  E P Rogakou; W Nieves-Neira; C Boon; Y Pommier; W M Bonner
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

Review 9.  DNA damage checkpoints: from initiation to recovery or adaptation.

Authors:  Jiri Bartek; Jiri Lukas
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

10.  The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.

Authors:  Sirisha Peddibhotla; Michael H Lam; Maria Gonzalez-Rimbau; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-16       Impact factor: 11.205

View more
  12 in total

1.  Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy.

Authors:  Stephen L Abrams; Linda S Steelman; John G Shelton; William Chappell; Jörg Bäsecke; Franca Stivala; Marco Donia; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; James A McCubrey
Journal:  Cell Cycle       Date:  2010-05-15       Impact factor: 4.534

2.  The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy.

Authors:  Stephen L Abrams; Linda S Steelman; John G Shelton; Ellis W T Wong; William H Chappell; Jörg Bäsecke; Franca Stivala; Marco Donia; Ferdinando Nicoletti; Massimo Libra; Alberto M Martelli; James A McCubrey
Journal:  Cell Cycle       Date:  2010-05-10       Impact factor: 4.534

3.  Alternative Chk1-independent S/M checkpoint in somatic cells that prevents premature mitotic entry.

Authors:  Doaa Hussein Zineldeen; Noha Mohamed Shafik; Sheng Fan Li
Journal:  Med Oncol       Date:  2017-03-27       Impact factor: 3.064

4.  Numerical chromosomal instability mediates susceptibility to radiation treatment.

Authors:  Samuel F Bakhoum; Lilian Kabeche; Matthew D Wood; Christopher D Laucius; Dian Qu; Ashley M Laughney; Gloria E Reynolds; Raymond J Louie; Joanna Phillips; Denise A Chan; Bassem I Zaki; John P Murnane; Claudia Petritsch; Duane A Compton
Journal:  Nat Commun       Date:  2015-01-21       Impact factor: 14.919

5.  Link between DNA damage and centriole disengagement/reduplication in untransformed human cells.

Authors:  Stephen Douthwright; Greenfield Sluder
Journal:  J Cell Physiol       Date:  2014-10       Impact factor: 6.384

Review 6.  Molecular mechanisms of garlic-derived allyl sulfides in the inhibition of skin cancer progression.

Authors:  Hsiao-Chi Wang; Jung Pao; Shuw-Yuan Lin; Lee-Yan Sheen
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

7.  Induction of robust de novo centrosome amplification, high-grade spindle multipolarity and metaphase catastrophe: a novel chemotherapeutic approach.

Authors:  V Pannu; P C G Rida; A Ogden; R Clewley; A Cheng; P Karna; M Lopus; R C Mishra; J Zhou; R Aneja
Journal:  Cell Death Dis       Date:  2012-07-12       Impact factor: 8.469

8.  Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

Authors:  Jackson R Taylor; Brian D Lehmann; William H Chappell; Stephen L Abrams; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2011-08

9.  NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring.

Authors:  Dorde Komljenovic; Manfred Wiessler; Waldemar Waldeck; Volker Ehemann; Ruediger Pipkorn; Hans-Hermann Schrenk; Jürgen Debus; Klaus Braun
Journal:  Theranostics       Date:  2016-01-01       Impact factor: 11.556

Review 10.  Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer.

Authors:  German A Pihan
Journal:  Front Oncol       Date:  2013-11-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.